This newslink doesn't exist or it was removed.
Go to Homempage.
Ars Technica USA Science June 07, 2023
Navigate Filter by topic Settings Front page layout Site theme - Jun 6, 2023 9:24 pm UTC / Boxes of Johnson & Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida. The Food and Drug Administration has withdrawn authorization for Johnson & Johnson's... + más
What Are the Duties of A Trustee? | Forbes
NFL Week 17 playoff picture and clinching scenarios: Bucs win NFC South; Giants clinch wild card | ESPN
WPTV USA Nation May 16, 2023
The U.S. Centers for Disease Control and Prevention announced recently that doses of the well-known Johnson & Johnson Janssen COVID-19 vaccine are no longer available in the U.S.The CDC said U.S. government stock of the vaccine expired on May 7, and ordered that any remaining... + más
J&J’s COVID vaccine is dead in the US; FDA revokes authorization | Ars Technica
RTTNews USA Health October 26, 2022
Ligand Pharmaceuticals Inc. () announced Wednesday that its licensing partner Janssen Biotech, Inc. has received approval from the FDA for Tecvayli or teclistamab for the treatment of relapsed or refractory multiple myeloma. Teclistamab is a T-cell redirecting, bispecific... + más
Don’t Pay for Cord-Blood Banking | The Atlantic
ALS drug wins FDA approval despite questionable data | ABC News
Bleacher Report USA Sports October 05, 2022
NBA fans got a glimpse of the future with Tuesday's head-to-head battle between Victor Wembanyama and Scoot Henderson.The matchup paired France's Metropolitans 92 against the G League Ignite (available on the new NBA app), but all eyes were on Wembanyama and Henderson... + más
Victor Wembanyama Hailed as NBA 'Create a Player' After G League Showcase Performance | Bleacher Report
Victor Wembanyama stars, Scoot Henderson leads G League Ignite to victory in No. 1 vs. No. 2 matchup of NBA draft prospects | ABC News
RTTNews USA Health December 07, 2023
Vanda Pharmaceuticals Inc. () has acquired U.S. and Canadian rights to PONVORY from Actelion Pharmaceuticals Ltd., a Johnson & Johnson Company. PONVORY is approved by the FDA and Health Canada to treat adults with relapsing forms of multiple sclerosis, to include clinically... + más
Meme-stock era record falls: Retail traders dumped $1.5 billion a day into U.S. equities in January | MarketWatch
About iurex | Privacy Policy | Disclaimer |